Abbott (ABT) Tops Q2 EPS by 30c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
July 20, 2022 7:30 AM EDTSales growth of 10.1 percent; organic sales growth of 14.3 percentGAAP diluted EPS growth of 72.7 percent; adjusted diluted EPS growth of 22.2 percentGlobal COVID-19 testing-related sales of $2.3 billion in the second quarterContinues to strengthen portfolio with new product approvals
ABBOTT PARK, Ill., July 20, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022.
Second-quarter sales of $11.3 billion increased 10.1 percent on a reported basis... More